Unreported by the mainstream/legacy media, a major scientific review published in 2025 found that coenzyme Q10 supplementation can significantly reduce systolic blood pressure, the top number in a blood pressure test, higher readings for which are strongly linked to an increased risk of heart attacks, strokes, and premature death. Analyzing 45 randomized controlled trials involving adults with a wide range of health conditions, researchers concluded that coenzyme Q10 may offer meaningful cardiovascular benefits, particularly when taken for more than eight weeks and at doses below 200 milligrams per day. The findings add to a growing body of evidence showing that micronutrients can play an important role in preventing and controlling high blood pressure and related cardiovascular problems. At a time when millions of people worldwide are struggling with hypertension despite drug treatment, the urgent need for doctors and patients to understand the potential of nutritional approaches has become impossible to ignore.